Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2024-514642-37-00Phase 4Authorised
Phase 4, randomised trial of midazolam in Perioperative anxiety (2 arms), sponsored by UZ Brussel. Primary endpoint: Perioperative anxiety (mYPAS and parental 5-point anxiety scale). Planned start Jul 2024; status: authorised.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2024-514642-37-00.